FDA NDC Directory · JSON-LD · Markdown

Adzenys XR-ODT

NDC 70165-005 · HUMAN PRESCRIPTION DRUG · TABLET, ORALLY DISINTEGRATING

Generic nameAmphetamine
Labeler / ManufacturerNeos Therapeutics Brands, LLC
Marketing categoryNew Drug Application (innovator) · App NDA204326
Dosage form / routeTABLET, ORALLY DISINTEGRATING · ORAL
Active ingredientsAMPHETAMINE (3.1 mg/1)
Marketing started20160216
Package count1

External sources

Source: openFDA. Public-domain (CC0).